Tudor Investment Corp ET AL Has $565,000 Stake in Indivior PLC (NASDAQ:INDV)

Tudor Investment Corp ET AL lifted its position in Indivior PLC (NASDAQ:INDV - Free Report) by 113.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 45,478 shares of the company's stock after buying an additional 24,137 shares during the quarter. Tudor Investment Corp ET AL's holdings in Indivior were worth $565,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. bought a new position in Indivior during the fourth quarter worth $56,000. Stifel Financial Corp raised its stake in shares of Indivior by 24.0% in the 4th quarter. Stifel Financial Corp now owns 12,675 shares of the company's stock valued at $158,000 after buying an additional 2,450 shares in the last quarter. Jane Street Group LLC acquired a new position in shares of Indivior in the 3rd quarter valued at $180,000. Rathbones Group PLC raised its stake in shares of Indivior by 11.6% in the 4th quarter. Rathbones Group PLC now owns 14,284 shares of the company's stock valued at $183,000 after buying an additional 1,483 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. acquired a new position in shares of Indivior in the 4th quarter valued at $359,000. 60.33% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently weighed in on INDV. Rodman & Renshaw began coverage on shares of Indivior in a report on Tuesday, January 28th. They issued a "buy" rating and a $16.00 target price on the stock. Piper Sandler decreased their price objective on shares of Indivior from $16.00 to $13.00 and set an "overweight" rating on the stock in a report on Thursday, March 6th. Finally, RODMAN&RENSHAW raised shares of Indivior to a "strong-buy" rating in a report on Tuesday, January 28th.

Indivior Price Performance

Shares of INDV traded down $0.10 during mid-day trading on Wednesday, hitting $11.10. 185,683 shares of the company's stock were exchanged, compared to its average volume of 996,068. The company has a market cap of $1.53 billion, a PE ratio of -31.70 and a beta of 0.98. Indivior PLC has a 52 week low of $7.33 and a 52 week high of $18.59. The company has a 50-day simple moving average of $10.02 and a 200 day simple moving average of $10.59.

Indivior (NASDAQ:INDV - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.19. Indivior had a negative return on equity of 241.73% and a negative net margin of 3.96%. The business had revenue of $266.00 million during the quarter, compared to the consensus estimate of $240.13 million. On average, analysts anticipate that Indivior PLC will post 1.22 earnings per share for the current year.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.